Advertisement
U.S. markets closed
  • S&P 500

    5,123.41
    -75.65 (-1.46%)
     
  • Dow 30

    37,983.24
    -475.84 (-1.24%)
     
  • Nasdaq

    16,175.09
    -267.10 (-1.62%)
     
  • Russell 2000

    2,003.17
    -39.43 (-1.93%)
     
  • Crude Oil

    85.49
    +0.47 (+0.55%)
     
  • Gold

    2,359.30
    -13.40 (-0.56%)
     
  • Silver

    28.05
    -0.20 (-0.71%)
     
  • EUR/USD

    1.0645
    -0.0086 (-0.80%)
     
  • 10-Yr Bond

    4.4990
    -0.0770 (-1.68%)
     
  • GBP/USD

    1.2449
    -0.0106 (-0.85%)
     
  • USD/JPY

    153.2420
    +0.0390 (+0.03%)
     
  • Bitcoin USD

    67,284.72
    -3,307.13 (-4.68%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,995.58
    +71.78 (+0.91%)
     
  • Nikkei 225

    39,523.55
    +80.92 (+0.21%)
     

Modular Medical to Attend the Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Modular Medical, Inc.

SAN DIEGO, CA / ACCESSWIRE / November 14, 2023 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced it will be presenting at the Benchmark Company's 12th Annual Discovery One-on-One Investor Conference to be held Thursday, December 7, 2023 at the New York Athletic Club in New York City. Jeb Besser, CEO, is scheduled to host one-on-one meetings with analysts and investors throughout the day.

The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format. To schedule a one-on-one meeting with the Company, you may submit your request online via the link provided upon registration. To register for the conference, please visit https://www.meetmax.com/sched/event_99181/investor_reg_new.html?attendee_role_id=INVESTOR

About The Benchmark Company

The Benchmark Company is an institutionally focused, research driven, sales trading and investment banking firm. We were founded in 1988 and are headquartered in New York City. Our focus is on fostering the long-term success of our corporate clients through raising capital, providing strategic advisory services, generating insightful research, and developing institutional sponsorship by leveraging the firm's sales, trading, and equity research capabilities. https://www.benchmarkcompany.com.

About Modular Medical

Modular Medical, Inc. (Nasdaq: MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

All trademarks mentioned herein are the property of their respective owners.

CONTACT:

Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com

SOURCE: Modular Medical, Inc.



View source version on accesswire.com:
https://www.accesswire.com/802489/modular-medical-to-attend-the-benchmark-companys-upcoming-discovery-one-on-one-investor-conference

Advertisement